IL21 and psoriasis: JAK inhibitors suppress the JAK/STAT signaling pathways and, thus, block the effects of inflammatory cytokines, such as IL-6, IFN-γ, IL-22, and IL-21, which are involved in the pathogenesis of psoriasis.